Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. [electronic resource] by
- Nabholtz, J M
- Abrial, C
- Mouret-Reynier, M A
- Dauplat, M M
- Weber, B
- Gligorov, J
- Forest, A M
- Tredan, O
- Vanlemmens, L
- Petit, T
- Guiu, S
- Van Praagh, I
- Jouannaud, C
- Dubray-Longeras, P
- Tubiana-Mathieu, N
- Benmammar, K E
- Kullab, S
- Bahadoor, M R K
- Radosevic-Robin, N
- Kwiatkowski, F
- Desrichard, A
- Cayre, A
- Uhrhammer, N
- Chalabi, N
- Chollet, P
- Penault-Llorca, F
Producer: 20151116
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|